Researchers from the Johns Hopkins Bloomberg School of Public Health supported the first blood center in the U.S. to be granted full FDA approval to provide convalescent plasma to immunocompromised ...

Laser plasma acceleration is a potentially disruptive technology: It could be used to build far more compact accelerators and open up new use cases in fundamental research, industry and health.